MX2009003039A - Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer. - Google Patents
Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer.Info
- Publication number
- MX2009003039A MX2009003039A MX2009003039A MX2009003039A MX2009003039A MX 2009003039 A MX2009003039 A MX 2009003039A MX 2009003039 A MX2009003039 A MX 2009003039A MX 2009003039 A MX2009003039 A MX 2009003039A MX 2009003039 A MX2009003039 A MX 2009003039A
- Authority
- MX
- Mexico
- Prior art keywords
- antibody
- cancer
- treatment
- inhibiting
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Abstract
La presente invención tiene por objeto la utilización de al menos un anticuerpo, o uno de sus fragmentos funcionales, capaz de unirse a la proteína CD151 e inhibir así el crecimiento tumoral para la preparación de un medicamento destinado al tratamiento del cáncer. La invención pretende igualmente una composición para el tratamiento del cáncer, que comprende como principio activo al menos un anticuerpo anti-CD151, o uno de sus fragmentos funcionales, capaz de unirse a la proteína CD151 y/o de inhibir el desarrollo de tumores primarios y/o de inhibir su actividad promotora de metástasis, pudiendo consistir dichos anticuerpos en los anticuerpos TS151 y/o TS151r.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609135A FR2907341B1 (fr) | 2006-10-18 | 2006-10-18 | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
PCT/FR2007/001688 WO2008049990A2 (fr) | 2006-10-18 | 2007-10-15 | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009003039A true MX2009003039A (es) | 2009-04-02 |
Family
ID=37866318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009003039A MX2009003039A (es) | 2006-10-18 | 2007-10-15 | Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer. |
Country Status (28)
Country | Link |
---|---|
US (2) | US8178096B2 (es) |
EP (1) | EP2079482B1 (es) |
JP (2) | JP5757646B2 (es) |
KR (1) | KR101521863B1 (es) |
CN (1) | CN101528256B (es) |
AT (1) | ATE499387T1 (es) |
AU (1) | AU2007310763B2 (es) |
BR (1) | BRPI0717455A2 (es) |
CA (1) | CA2665912C (es) |
DE (1) | DE602007012743D1 (es) |
DK (1) | DK2079482T3 (es) |
ES (1) | ES2361696T3 (es) |
FR (1) | FR2907341B1 (es) |
HK (1) | HK1132904A1 (es) |
HR (1) | HRP20110374T1 (es) |
IL (1) | IL198043A (es) |
MA (1) | MA30777B1 (es) |
MX (1) | MX2009003039A (es) |
NO (1) | NO20091919L (es) |
NZ (1) | NZ575781A (es) |
PL (1) | PL2079482T3 (es) |
PT (1) | PT2079482E (es) |
RS (1) | RS51729B (es) |
RU (1) | RU2464041C2 (es) |
SI (1) | SI2079482T1 (es) |
TN (1) | TN2009000144A1 (es) |
UA (1) | UA99601C2 (es) |
WO (1) | WO2008049990A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873699B1 (fr) * | 2004-07-29 | 2009-08-21 | Pierre Fabre Medicament Sa | Nouveaux anticorps anti igf ir rt leurs utilisations |
FR2907341B1 (fr) * | 2006-10-18 | 2012-08-17 | Pf Medicament | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
FR2929946B1 (fr) * | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
EP2308897A1 (en) * | 2009-10-09 | 2011-04-13 | Pierre Fabre Medicament | Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer |
EP2371863A1 (en) * | 2010-03-30 | 2011-10-05 | Pierre Fabre Médicament | Humanized anti CXCR4 antibodies for the treatment of cancer |
WO2012131680A2 (en) | 2011-03-28 | 2012-10-04 | Yeda Research And Development Co. Ltd. | Compositions and methods for treating inflammation |
CN102605057A (zh) * | 2012-02-28 | 2012-07-25 | 芮屈生物技术(上海)有限公司 | 癌症病变前期CD151的mRNA水平原位杂交检测试剂盒及检测方法和应用 |
US9982057B2 (en) | 2014-11-17 | 2018-05-29 | Pelican Therapeutics, Inc. | Human TNFRSF25 antibody |
CA3026652A1 (en) | 2016-06-09 | 2017-12-14 | Pelican Therapeutics, Inc. | Anti-tnfrsf25 antibodies |
CN108690136B (zh) * | 2017-04-05 | 2022-09-20 | 凯惠科技发展(上海)有限公司 | 一种人源化抗tpbg抗体及其制备方法、其偶联物和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
WO1999066027A1 (en) * | 1998-06-15 | 1999-12-23 | The Research Foundation Of State University Of New York | Monoclonal antibodies that recognize antigens associated with tumor metastasis |
JP2003189851A (ja) * | 2001-12-28 | 2003-07-08 | Japan Science & Technology Corp | 抗ヒトcd151モノクローナル抗体産生ハイブリドーマ |
JP2003321494A (ja) * | 2002-02-26 | 2003-11-11 | Daiichi Fine Chemical Co Ltd | プロmmp−7の活性化調節方法 |
EP2041175A4 (en) * | 2006-06-23 | 2011-03-16 | Augmenta Biolog Llc | TARGETED IMMUNOJUGATE |
FR2907341B1 (fr) * | 2006-10-18 | 2012-08-17 | Pf Medicament | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
FR2929946B1 (fr) * | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
-
2006
- 2006-10-18 FR FR0609135A patent/FR2907341B1/fr not_active Expired - Fee Related
-
2007
- 2007-10-15 EP EP07858450A patent/EP2079482B1/fr active Active
- 2007-10-15 MX MX2009003039A patent/MX2009003039A/es active IP Right Grant
- 2007-10-15 RS RS20110202A patent/RS51729B/en unknown
- 2007-10-15 US US12/311,682 patent/US8178096B2/en not_active Expired - Fee Related
- 2007-10-15 SI SI200730592T patent/SI2079482T1/sl unknown
- 2007-10-15 CA CA2665912A patent/CA2665912C/fr not_active Expired - Fee Related
- 2007-10-15 ES ES07858450T patent/ES2361696T3/es active Active
- 2007-10-15 RU RU2009118440/15A patent/RU2464041C2/ru not_active IP Right Cessation
- 2007-10-15 DK DK07858450.5T patent/DK2079482T3/da active
- 2007-10-15 BR BRPI0717455-1A2A patent/BRPI0717455A2/pt active Search and Examination
- 2007-10-15 PL PL07858450T patent/PL2079482T3/pl unknown
- 2007-10-15 AU AU2007310763A patent/AU2007310763B2/en not_active Ceased
- 2007-10-15 UA UAA200904808A patent/UA99601C2/ru unknown
- 2007-10-15 JP JP2009532841A patent/JP5757646B2/ja not_active Expired - Fee Related
- 2007-10-15 PT PT07858450T patent/PT2079482E/pt unknown
- 2007-10-15 NZ NZ575781A patent/NZ575781A/en not_active IP Right Cessation
- 2007-10-15 DE DE602007012743T patent/DE602007012743D1/de active Active
- 2007-10-15 KR KR1020097010125A patent/KR101521863B1/ko active IP Right Grant
- 2007-10-15 AT AT07858450T patent/ATE499387T1/de active
- 2007-10-15 CN CN2007800389060A patent/CN101528256B/zh not_active Expired - Fee Related
- 2007-10-15 WO PCT/FR2007/001688 patent/WO2008049990A2/fr active Application Filing
-
2009
- 2009-04-03 MA MA31758A patent/MA30777B1/fr unknown
- 2009-04-06 IL IL198043A patent/IL198043A/en active IP Right Grant
- 2009-04-17 TN TNP2009000144A patent/TN2009000144A1/fr unknown
- 2009-05-18 NO NO20091919A patent/NO20091919L/no not_active Application Discontinuation
- 2009-11-10 HK HK09110445.1A patent/HK1132904A1/xx not_active IP Right Cessation
-
2011
- 2011-05-19 HR HR20110374T patent/HRP20110374T1/hr unknown
-
2012
- 2012-04-16 US US13/447,626 patent/US20120219569A1/en not_active Abandoned
-
2013
- 2013-07-09 JP JP2013143422A patent/JP5723420B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009003039A (es) | Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer. | |
MX349198B (es) | Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos. | |
WO2010019702A3 (en) | Ddr1-binding agents and methods of use thereof | |
WO2008142303A3 (fr) | Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer | |
PH12015500084A1 (en) | Rspo3 binding agents and uses thereof | |
UA106194C2 (ru) | Диагностика и лечение рака с применением антитела к ereg | |
WO2010005566A3 (en) | Notch-binding agents and antagonists and methods of use thereof | |
BRPI0514721A (pt) | uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo | |
WO2005120557A3 (en) | Inhibition of macrophage-stimulating protein receptor (ron) | |
IL214325A (en) | Antibody against cmet, a drug that includes and uses it | |
SG158112A1 (en) | Hepatocyte growth factor (hgf) binding proteins | |
WO2008091641A3 (en) | Compositions and methods for diagnosing and treating cancer | |
EP2175879A4 (en) | TREATMENT OF DISEASES ASSOCIATED WITH PRION PROTEIN | |
IL189452A0 (en) | Therapy with cd4 binding peptides and radiation | |
WO2009142738A3 (en) | Compositions and methods for diagnosing and treating cancer | |
SI1869185T1 (sl) | Konjugat ki obsega protein P za zdravljenje raka | |
WO2007007152A3 (en) | Anti-madcam antibodies to treat metastatic cancers and chloroma | |
HK1116198A1 (en) | Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth | |
FR2929519B1 (fr) | Utilisation d'un anticorps anti-cd151 pour le traitement precoce des cancers. | |
UA98756C2 (ru) | Антитело, которое связывается с cd38, для лечения заболевания, опосредованного cd38 | |
UA101671C2 (ru) | Notch-связующие агенты и антагонисты и способы их применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |